{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:53:49Z","timestamp":1780379629930,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":1341,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1124\/jpet.120.000166","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T20:45:11Z","timestamp":1616532311000},"page":"284-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Inhibition of Glucose-6-Phosphate Dehydrogenase Activity Attenuates Right Ventricle Pressure and Hypertrophy Elicited by VEGFR Inhibitor + Hypoxia"],"prefix":"10.1016","volume":"377","author":[{"given":"Atsushi","family":"Kitagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Waddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan F.","family":"McMurtry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7453-8303","authenticated-orcid":false,"given":"Sachin A.","family":"Gupte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.120.000166_bib1","doi-asserted-by":"crossref","first-page":"10071","DOI":"10.1038\/ncomms10071","article-title":"Acute loss of TET function results in aggressive myeloid cancer in mice","volume":"6","author":"An","year":"2015","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.120.000166_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/2045893217701438","article-title":"The cancer theory of pulmonary arterial hypertension","volume":"7","author":"Boucherat","year":"2017","journal-title":"Pulm Circ"},{"key":"10.1124\/jpet.120.000166_bib3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrm3598","article-title":"The mechanisms of Hedgehog signalling and its roles in development and disease","volume":"14","author":"Briscoe","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/jpet.120.000166_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13072-018-0247-4","article-title":"Specific functions of TET1 and TET2 in regulating mesenchymal cell lineage determination","volume":"12","author":"Cakouros","year":"2019","journal-title":"Epigenetics Chromatin"},{"key":"10.1124\/jpet.120.000166_bib5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/HYPERTENSIONAHA.119.13458","article-title":"Epigenetic modulation in the initiation and progression of pulmonary hypertension","volume":"74","author":"Cheng","year":"2019","journal-title":"Hypertension"},{"key":"10.1124\/jpet.120.000166_bib6","doi-asserted-by":"crossref","first-page":"L287","DOI":"10.1152\/ajplung.00229.2014","article-title":"Hypoxia-induced glucose-6-phosphate dehydrogenase overexpression and -activation in pulmonary artery smooth muscle cells: implication in pulmonary hypertension","volume":"308","author":"Chettimada","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/jpet.120.000166_bib7","doi-asserted-by":"crossref","first-page":"L64","DOI":"10.1152\/ajplung.00002.2012","article-title":"Glc-6-PD and PKG contribute to hypoxia-induced decrease in smooth muscle cell contractile phenotype proteins in pulmonary artery","volume":"303","author":"Chettimada","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/jpet.120.000166_bib8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1089\/ars.2017.7217","article-title":"Hallmarks of pulmonary hypertension: mesenchymal and inflammatory cell metabolic reprogramming","volume":"28","author":"D\u2019Alessandro","year":"2018","journal-title":"Antioxid Redox Signal"},{"key":"10.1124\/jpet.120.000166_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1165\/rcmb.2017-0260OC","article-title":"Role of the aryl hydrocarbon receptor in sugen 5416-induced experimental pulmonary hypertension","volume":"58","author":"Dean","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/jpet.120.000166_bib10","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra035488","article-title":"Pulmonary arterial hypertension","volume":"351","author":"Farber","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.120.000166_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cellsig.2018.08.019","article-title":"Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity","volume":"52","author":"Frismantiene","year":"2018","journal-title":"Cell Signal"},{"key":"10.1124\/jpet.120.000166_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1124\/jpet.301.1.299","article-title":"Inhibitors of pentose phosphate pathway cause vasodilation: involvement of voltage-gated potassium channels","volume":"301","author":"Gupte","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000166_bib13","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1021\/jm300317k","article-title":"Novel steroid inhibitors of glucose 6-phosphate dehydrogenase","volume":"55","author":"Hamilton","year":"2012","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.120.000166_bib14","doi-asserted-by":"crossref","first-page":"L386","DOI":"10.1152\/ajplung.00327.2019","article-title":"Pluripotent hematopoietic stem cells augment \u03b1-adrenergic receptor-mediated contraction of pulmonary artery and contribute to the pathogenesis of pulmonary hypertension","volume":"318","author":"Hashimoto","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/jpet.120.000166_bib15","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1113\/JP275857","article-title":"Mechanisms contributing to persistently activated cell phenotypes in pulmonary hypertension","volume":"597","author":"Hu","year":"2019","journal-title":"J Physiol"},{"key":"10.1124\/jpet.120.000166_bib16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/HYPERTENSIONAHA.117.09059","article-title":"Pregnancy reprograms large-conductance Ca2+-activated K+ channel in uterine arteries: roles of ten-eleven translocation methylcytosine dioxygenase 1-mediated active demethylation","volume":"69","author":"Hu","year":"2017","journal-title":"Hypertension"},{"key":"10.1124\/jpet.120.000166_bib17","doi-asserted-by":"crossref","first-page":"L773","DOI":"10.1152\/ajplung.00001.2020","article-title":"Hypoxic activation of glucose-6-phosphate dehydrogenase controls the expression of genes involved in the pathogenesis of pulmonary hypertension through the regulation of DNA methylation","volume":"318","author":"Joshi","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/jpet.120.000166_bib18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1534\/g3.112.003202","article-title":"oPOSSUM-3: advanced analysis of regulatory motif over-representation across genes or ChIP-Seq datasets","volume":"2","author":"Kwon","year":"2012","journal-title":"G3 (Bethesda)"},{"key":"10.1124\/jpet.120.000166_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S2213-2600(16)00027-8","article-title":"Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis","volume":"4","author":"Lajoie","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1124\/jpet.120.000166_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.semcdb.2018.10.009","article-title":"Proteostasis in the Hedgehog signaling pathway","volume":"93","author":"Liu","year":"2019","journal-title":"Semin Cell Dev Biol"},{"key":"10.1124\/jpet.120.000166_bib21","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.113.002887","article-title":"Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity","volume":"128","author":"Liu","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1124\/jpet.120.000166_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2009.04.018","article-title":"Cellular and molecular basis of pulmonary arterial hypertension","volume":"54","author":"Morrell","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.120.000166_bib23","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/cas.12484","article-title":"TET2 as an epigenetic master regulator for normal and malignant hematopoiesis","volume":"105","author":"Nakajima","year":"2014","journal-title":"Cancer Sci"},{"key":"10.1124\/jpet.120.000166_bib24","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1161\/CIRCULATIONAHA.119.044320","article-title":"Novel mutations and decreased expression of the epigenetic regulator TET2 in pulmonary arterial hypertension","volume":"141","author":"Potus","year":"2020","journal-title":"Circulation"},{"key":"10.1124\/jpet.120.000166_bib25","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0140-6736(03)13167-4","article-title":"Primary pulmonary hypertension","volume":"361","author":"Runo","year":"2003","journal-title":"Lancet"},{"key":"10.1124\/jpet.120.000166_bib26","doi-asserted-by":"crossref","first-page":"e0153780","DOI":"10.1371\/journal.pone.0153780","article-title":"MEF2C-MYOCD and Leiomodin1 suppression by miRNA-214 promotes smooth muscle cell phenotype switching in pulmonary arterial hypertension","volume":"11","author":"Sahoo","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/jpet.120.000166_bib27","doi-asserted-by":"crossref","first-page":"L1013","DOI":"10.1152\/ajplung.00217.2009","article-title":"Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure","volume":"297","author":"Stenmark","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/jpet.120.000166_bib28","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/678508","article-title":"The Sugen 5416\/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up","volume":"4","author":"Vitali","year":"2014","journal-title":"Pulm Circ"},{"key":"10.1124\/jpet.120.000166_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J Gen Physiol"},{"key":"10.1124\/jpet.120.000166_bib30","doi-asserted-by":"crossref","first-page":"L780","DOI":"10.1152\/ajplung.90295.2008","article-title":"Modulation of pulmonary vascular smooth muscle cell phenotype in hypoxia: role of cGMP-dependent protein kinase and myocardin","volume":"296","author":"Zhou","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"updated-by":[{"DOI":"10.1124\/jpet.120.000166err","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000}}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524270671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524270671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.000166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T16:54:47Z","timestamp":1740675287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524270671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0022356524270671"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.000166","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Glucose-6-Phosphate Dehydrogenase Activity Attenuates Right Ventricle Pressure and Hypertrophy Elicited by VEGFR Inhibitor + Hypoxia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.000166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The Author(s)","name":"copyright","label":"Copyright"}]}}